Earlier we have demonstrated that inhibition of
endothelin biosynthesis ameliorates
endotoxemia-induced
inducible nitric oxide synthase (iNOS) activation and phosphorylation of p38-mitogen activated
protein kinase (pp38-MAPK). Therefore, in the present study, we tested the hypothesis that activation of
endothelin (ET)-1 biosynthesis using bigET-1 during early
sepsis would upregulate iNOS and affect myocardial function in the rat. Male Sprague-Dawley rats (350-400 g) were anesthetised using
Nembutal (50 mg/kg, i.p.) and jugular vein, tail artery (Mean arterial pressure, MAP) and right carotid arteries (advanced to left ventricle, LV) were cannulated. The rats were randomly divided into saline-, bigET-1- and C-terminal fragment of bigET-1 (bigET-1(22-38))-treated groups.
Sepsis was induced using i.p. injection of cecal inoculum obtained from a donor rat (200 mg/kg in 5 ml 5% sterile
dextrose water, D5W).
Sham animals received an i.p. injection of D5W (5 ml/kg). MAP and LVP were recorded and cardiodynamic parameters were calculated at 0, 2, 6, 12 and 24 h post
sham or
sepsis-induction. A significant elevation in LV isovolumic relaxation rate constant (tau), LV end diastolic pressure (LVEDP) and rate pressure product (RPP) was observed in vehicle-treated septic group at 24 h. BigET-1 significantly increased concentration of LV ET-1 both in
sham and septic groups. BigET-1 elevated tau and LVEDP both in
sham and septic animals as early as 12 h which persisted through 24 h. However, bigET-1(22-38) elevated LVEDP in septic group at 24 h but not in
sham group. BigET-1 accentuated the levels of plasma
nitric oxide byproduct (NOx) levels in both
sham and septic animals at 6, 12 and 24 h.
Sepsis increased myocardial iNOS at 24 h. BigET-1 significantly upregulated expression of myocardial iNOS and pp38-MAPK. The data suggest that increased substrate availability for ET-1 at the time of
sepsis-induction contributes in diastolic dysfunction, iNOS activation and p38-MAPK phosphorylation.